DSIP is now one of the most studied nonapeptides for which the primary receptor has never been identified
Weekly subcutaneous VK2735, a GIP/GLP-1 receptor dual agonist, for weight management: Phase 2, randomized, 13-week VENTURE study
3rd party lab tested for purity, safety, and potency
In preclinical models, IGF-1 has been found to reduce the inflammatory response, protect neurons from oxidative damage, and improve cognitive outcomes following I/R injury
Specialty Functional Tests Urine organic acid test (OAT): Especially with extensive gastrointestinal symptoms, this assays examines the urine for evidence of yeast, Clostridia bacteria, and other important factors like indirect nutritional factors and mitochondrial function
Both are available nationwide with no insurance required and are HSA/FSA eligible